Completed from United Kingdom
The Master Certificate in Health Economics and Market Access exceeded my expectations. The curriculum aligned perfectly with my goal of moving into health policy analysis, and the modules on cost‑effectiveness modelling gave me hands‑on experience with real‑world datasets. I particularly appreciated the case studies from the NHS, which allowed me to apply theoretical concepts directly to UK market access challenges. The reading materials were up‑to‑date and the interactive webinars facilitated deep discussions with industry experts. Overall, the course was professionally delivered and has already opened doors for me at a leading consultancy.
I took this program to boost my knowledge of health economics for a new role in a biotech firm, and it totally delivered. The lessons on pricing strategies were super practical—I could actually draft a pricing model for our upcoming oncology product the week after the class. The course videos were clear and the supplementary slides were easy to follow. I loved the group projects; they felt like real consulting gigs. The only thing I’d tweak is a bit more focus on US‑specific reimbursement pathways, but overall I’m really happy with what I learned.
Wow, what an energizing experience! The course gave me exactly the toolkit I needed to understand market access across Europe. I learned how to conduct budget impact analyses and, thanks to the interactive Excel workshops, I can now build robust models for German statutory health insurance. The instructors were enthusiastic and the real‑world examples—from German HTA bodies to EU pricing negotiations—made the content instantly relevant. I’m now confidently leading my company’s market access strategy and feel fully prepared for the challenges ahead.
The Master Certificate in Health Economics and Market Access provided a detailed and comprehensive overview of the field, which was exactly what I needed to transition from clinical research to health policy. The module on pharmacoeconomics introduced me to advanced cost‑utility analysis techniques, and the hands‑on assignments using R helped solidify my analytical skills. Course materials were well‑structured, with up‑to‑date journal articles and clear slide decks. I especially valued the forum discussions with peers from different countries, which broadened my perspective on global market access strategies. The program was thorough and has equipped me with actionable knowledge for my new role at a pharmaceutical company.
